SciELO - Scientific Electronic Library Online

 
vol.41 número5Adecuación del tratamiento con canaglifozina tras alerta de farmacovigilancia en un área de gestión sanitariaAnálisis de coste-utilidad de la combinación a dosis fijas de dolutegravir/abacavir/lamivudina como tratamiento inicial de pacientes con VIH + en España índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Farmacia Hospitalaria

versión On-line ISSN 2171-8695versión impresa ISSN 1130-6343

Resumen

JUANBELTZ, Regina et al. Complementary medicine use in cancer patients receiving intravenous antineoplastic treatment. Farm Hosp. [online]. 2017, vol.41, n.5, pp.589-600. ISSN 2171-8695.  https://dx.doi.org/10.7399/fh.10805.

Objective:

Complementary and alternative medicine (CAM) use has grown considerably, although there is little research on the topic in Spain. The aim of this study was to determine the prevalence of complementary medicine use in adult cancer patients at the same time as they were receiving conventional treatment in a Spanish referral cancer centre.

Method:

An observational, descriptive, cross-sectional study was conducted in the Ambulatory Treatment Unit during 2 consecutive weeks in March 2015. Adult patients who were receiving intravenous chemotherapy were included. Study variables were obtained from a questionnaire and medical records.

Results:

316 patients were included. 32.3% of the patients reported complementary medicine use during this period and 89% were ingesting products by mouth, herbs and natural products being the most commonly used. 81% of patients started to use complementary medicine after diagnosis, and family/friends were the main source of information. 65% of the patients reported improvements, especially in their physical and psychological well-being. Significant predictors of CAM use were female gender (P=0.028), younger age (P<0.001), and secondary education (P=0.009).

Conclusions:

A large proportion of cancer patients receiving intravenous chemotherapy also use complementary medicine, which they mainly take by mouth. Due to the risk of chemotherapy-CAM interactions, it is important for health-professionals to keep abreast of research on this issue, in order to provide advice on its potential benefits and risks.

Palabras clave : Complementary therapies; Neoplasms; Antineoplastic agents; Medicinal plants; Homeopathy; Prevalence; Spain.

        · resumen en Español     · texto en Español | Inglés     · Inglés ( pdf )